Six of the most common cancers are on the rise, and – most disturbingly – are occurring in younger populations.
In a report published on Jan. 17, the American Cancer Society (ACS) estimated that new cancer cases will surpass 2 million in 2024, hitting a record high.
While the risk of dying from cancer has declined, cancer incidence has been rising for six of the most common cancers: breast, prostate, endometrial, pancreatic, kidney, and melanoma.
The new estimates represent a 2 percent increase from the ACS’s 2023 estimates. Continue reading
In reality, a person very rarely dies of cancer. It is always starvation and toxicity. As the malignant tumor grows it gives off waste products, which must be eliminated through the colon, liver, kidneys, lungs and skin. These waste products accumulate and gradually overburden the body. Most persons then die of toxemia.
Nearly 17,000 people across six countries may have died because they took hydroxychloroquine (HQC) during the first wave of COVID-19 in 2020, according to a new analysis published by French researchers.
The Google-owned YouTube video platform is 
“We have lost so much. Just like everybody else,” said one member doing a group zoom meeting.
Uncle Sam has made some progress in reducing cancer drug shortages by working with manufacturers to restart U.S. production facilities that were previously shut down, as well as securing vital overseas supplies.
Health authorities in Punjab, Pakistan, where the incident took place say that Avastin, a cancer drug injection made by Swiss pharmaceutical giant Roche, say they are currently probing two distributors of the shot, which contains the active ingredient bevacizumab.
As studies emerge on the COVID-19 mRNA shot, several documented dangerous or deadly side effects are coming to light. Pathologist 
Excluding different doses and formulations, more than 140 brands of drugs will have their prices raised next month, the data showed.
Starting January 1, a drug that thousands of patients depend on to help them breathe will disappear from pharmacy shelves, and doctors are concerned patients may have delays switching to alternatives and getting them covered by insurance.
A few years ago, one of my students came to me and spoke about her mother who was undergoing treatment for breast cancer. She said her mother was losing her memory and her bearings, and was very worried because nobody knew what to do about her symptoms. The oncologist sent her to the psychiatrist. The psychiatrist sent her back, saying that her symptoms were a result of the cancer treatment.